BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38553406)

  • 1. Explainable artificial intelligence analysis of brachytherapy boost receipt in cervical cancer during the COVID-19 era.
    Ladbury C; Eustace N; Kassardjian A; Amini A; Chen YJ; Wang E; Kohut A; Tergas A; Han E; Song M; Glaser S
    Brachytherapy; 2024; 23(3):237-247. PubMed ID: 38553406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying disparities in brachytherapy delivery for locally advanced cervical cancer.
    Eakin A; Wairiri L; Stadtlander W; Bruegl A; Emerson J; Williamson C; Kahn J
    Brachytherapy; 2023; 22(4):461-467. PubMed ID: 37015846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of single insertion accelerated MR-image guided brachytherapy following chemo-radiation in locally advanced cervix cancer: modifying our EMBRACE during the COVID pandemic.
    Stevens MJ; Ko F; Martland J; Brown R; Bell L; Atyeo J; Yim J
    Radiat Oncol; 2023 Mar; 18(1):54. PubMed ID: 36941643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Body Radiation Therapy, Intensity-Modulated Radiation Therapy, and Brachytherapy Boost Modalities in Invasive Cervical Cancer: A Study of the National Cancer Data Base.
    OʼDonnell B; Shiao JC; Pezzi TA; Waheed N; Sharma S; Bonnen MD; Ludwig MS
    Int J Gynecol Cancer; 2018 Mar; 28(3):563-574. PubMed ID: 29324547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CVD22: Explainable artificial intelligence determination of the relationship of troponin to D-Dimer, mortality, and CK-MB in COVID-19 patients.
    Kırboğa KK; Küçüksille EU; Naldan ME; Işık M; Gülcü O; Aksakal E
    Comput Methods Programs Biomed; 2023 May; 233():107492. PubMed ID: 36965300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer.
    Huynh-Le MP; Klapheke A; Cress R; Mell LK; Yashar CM; Einck JP; Mundt AJ; Mayadev JS
    Brachytherapy; 2019; 18(5):612-619. PubMed ID: 31153760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Declining brachytherapy utilization for cervical cancer patients - Have we reversed the trend?
    Schad MD; Patel AK; Glaser SM; Balasubramani GK; Showalter TN; Beriwal S; Vargo JA
    Gynecol Oncol; 2020 Mar; 156(3):583-590. PubMed ID: 31924333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase II Trial of Stereotactic Ablative Radiation Therapy as a Boost for Locally Advanced Cervical Cancer.
    Albuquerque K; Tumati V; Lea J; Ahn C; Richardson D; Miller D; Timmerman R
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):464-471. PubMed ID: 31697990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer.
    Korenaga TK; Yoshida EJ; Pierson W; Chang J; Ziogas A; Swanson ML; Chapman JS; Sinha S; Chen LM
    Gynecol Oncol; 2022 Feb; 164(2):348-356. PubMed ID: 34865860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of a positive COVID-19 test on timeliness of radiation in patients receiving brachytherapy.
    Roach E; Hutten R; Johnson S; Suneja G; Tward J; Petereit D; Gaffney D
    Brachytherapy; 2024; 23(3):360-367. PubMed ID: 38395662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning From Past Respiratory Infections to Predict COVID-19 Outcomes: Retrospective Study.
    Sang S; Sun R; Coquet J; Carmichael H; Seto T; Hernandez-Boussard T
    J Med Internet Res; 2021 Feb; 23(2):e23026. PubMed ID: 33534724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of nodal boost irradiation and MR-based brachytherapy on oncologic outcomes in node-positive cervical cancer.
    Tiwari R; Narayanan GS; Reddy VP; Vishwanathan B; Narayanan S; Venugopal R
    Gynecol Oncol; 2021 Oct; 163(1):110-116. PubMed ID: 34304907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.
    Gill BS; Lin JF; Krivak TC; Sukumvanich P; Laskey RA; Ross MS; Lesnock JL; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1083-90. PubMed ID: 25216857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of sociodemographic and baseline patient characteristic differences in cervical cancer patients treated with either external beam or brachytherapy boost.
    Lu DJ; Atkins KM; Small W; Kamrava M
    Brachytherapy; 2022; 21(1):22-28. PubMed ID: 34895839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Explainable Machine Learning Model to Predict COVID-19 Severity Among Older Adults in the Province of Quebec.
    Rahimi S; Chu C; Grad R; Karanofsky M; Arsenault M; Ronquillo C; Vedel I; McGilton K; Wilchesky M
    Ann Fam Med; 2023 Jan; 21(21 Suppl 1):. PubMed ID: 36972530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
    Ito K; Shimizuguchi T; Karasawa K
    Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Control and Use of External Beam Parametrial Boost in the Era of Image-Guided Brachytherapy for Locally Advanced Cervical Cancer.
    Arya R; Giurcanu M; Jutzy JM; Peters P; Daily EW; Golden DW; McCall AR; Howard AR; Hasan Y; Son CH
    Am J Clin Oncol; 2021 Nov; 44(11):565-571. PubMed ID: 34456239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachytherapy outcome modeling in cervical cancer patients: A predictive machine learning study on patient-specific clinical, physical and dosimetric parameters.
    Abdalvand N; Sadeghi M; Mahdavi SR; Abdollahi H; Qasempour Y; Mohammadian F; Birgani MJT; Hosseini K
    Brachytherapy; 2022; 21(6):769-782. PubMed ID: 35933272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer.
    Robin TP; Amini A; Schefter TE; Behbakht K; Fisher CM
    Gynecol Oncol; 2016 Nov; 143(2):319-325. PubMed ID: 27640961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracervical blocks facilitate timely brachytherapy amidst COVID-19.
    Brunnhoelzl D; Hanania AN; Echeverria A; Sunde J; Tran C; Ludwig M
    Brachytherapy; 2021; 20(1):284-289. PubMed ID: 32891569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.